efforts have been devoted to increasing the intratumoral H 2 O 2 level with various H 2 O 2 -generating agents, such as glucose oxidase, [9] β-lapachone, [10] and Au nanoparticles. [11] In addition, to improve the antitumor effect, more and more therapeutic modalities, such as chemotherapy, [12] starvation therapy, [13] gas therapy, [14] photothermal therapy, [15] and PDT, [16] have been used in combination with CDT to address different targets. The anthracycline class antibiotic doxorubicin (DOX) has been widely used for the treatment of a range of cancers. [17] In aerobic conditions, DOX can elicit the production of superoxide radicals (O 2 •− ) by activating the nicotinamide adenine dinucleotide phosphate (NADPH) oxidases and further catalyzing the reaction of NADPH and oxygen (O 2 ). [18] O 2 •− can induce cancer cell death via oxidative damage to cellular components, which also increases the sensitivity of tumor cells to DOX. [19] Alternatively, superoxide dismutase (SOD) can convert the O 2 •− to H 2 O 2 , [20] which is the substrate of CDT. However, the hypoxic microenvironment of most solid tumors limits the therapeutic efficacy of DOX. Hence, alleviating the hypoxia in the tumor microenvironment may augment the sensitivity of tumor cells to DOX and also improve the therapeutic efficacy of CDT.
Owing to its high biocompatibility and efficient O 2 -evolving ability, calcium peroxide (CaO 2 ) has previously been utilized as an O 2 production material (Equation (1)) for improving PDT efficiency [21] and overcoming the hypoxia-induced DOX resistance in solid tumors. [22] Moreover, CaO 2 can dissolve in Combined chemo/chemodynamic therapy is a promising strategy to achieve an improved anticancer effect. However, the hypoxic microenvironment and limited amount of H 2 O 2 in most solid tumors severely restrict the efficacy of this treatment. Herein, the construction of a nanocatalytic medicine, CaO 2 @ DOX@ZIF-67, via a bottom-up approach is described. CaO 2 @DOX@ZIF-67 simultaneously supplies O 2 and H 2 O 2 to achieve improved chemo/chemodynamic therapy. In the weakly acidic environment within tumors, CaO 2 @ DOX@ZIF-67 is broken down to rapidly release the Fenton-like catalyst Co 2+ and the chemotherapy drug doxorubicin (DOX). The unprotected CaO 2 reacts with H 2 O to generate both O 2 and H 2 O 2 . The generated O 2 relieves the hypoxia in the tumor and further improve the efficacy of DOX. Meanwhile, the generated H 2 O 2 reacts with Co 2+ ions to produce highly toxic •OH through a Fenton-like reaction, resulting in improved chemodynamic therapy.
water to form H 2 O 2 under acidic conditions (Equation (2)). [23] Since CaO 2 can simultaneously produce O 2 
Herein, we designed a nanocatalytic medicine for coencapsulation of DOX and CaO 2 within a cobalt-based metal-organic framework (ZIF-67). The zeolitic imidazolate framework ZIF-67 is stable in physiologically neutral conditions, and can therefore prevent CaO 2 from reacting prematurely. However, ZIF-67 should decompose in the acidic environment within tumor and rapidly release Co 2+ , which can then catalyze the decomposition of H 2 O 2 to produce •OH through a Fenton-like reaction [24] to achieve efficient CDT. As illustrated in Scheme 1, CaO 2 nanoparticles were first prepared with PEG-200 as solvent and template. Then, DOX was coated onto the surface of the CaO 2 via coordination between DOX and Ca to form CaO 2 @DOX. To further isolate and protect the CaO 2 @DOX from external water, ZIF-67 was finally constructed on the surface of CaO 2 @DOX by an in situ synthesis method. This yielded the pH-responsive nanocatalytic medicine CaO 2 @DOX@ZIF-67. The outermost ZIF-67 layer will be disassembled in the acidic environment of tumor due to its pH sensitivity, resulting in rapid release of Co 2+ and DOX. At the same time, the unprotected CaO 2 will react with water to produce O 2 and H 2 O 2 . The generated H 2 O 2 will then be further catalyzed by Co 2+ ions to produce highly toxic •OH through a Fenton-like reaction, while the generated O 2 will improve the efficacy of DOX by alleviating the hypoxic conditions in the tumor. Therefore, this nanocatalytic medicine provides a novel strategy for improving the effectiveness of combined chemo/chemodynamic therapy.
The nanocatalytic medicine CaO 2 @DOX@ZIF-67 was synthesized by a bottom-up approach. First, CaO 2 was prepared via a hydrolysis-precipitation procedure reported in the literature. [25] Second, DOX was immobilized on the surface of CaO 2 to form CaO 2 @DOX by coordination reaction. [26] After modification with DOX, the nanoparticles had a more uniform morphology ( Figure S1a ,b, Supporting Information) and their diameters were larger ( Figure S1c , Supporting Information). In addition, compared with free DOX, the UV-vis absorption spectrum of CaO 2 @DOX exhibited a significant red-shift and two bands were observed at around 550 and 590 nm, which are characteristic of the Ca-DOX complex ( Figure S1d , Supporting Information). [26] Finally, ZIF-67 was constructed on the surface of CaO 2 @DOX by an in situ synthesis method. Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) images of CaO 2 @DOX@ZIF-67 revealed monodisperse nanospheres with a mean diameter of 200 nm (Figure 1a,b) . This was also confirmed by dynamic light scattering ( Figure S1c , Supporting Information). Figure 1c shows the elemental mapping of CaO 2 @DOX@ZIF-67, which indicates that Ca, O, Co, N, and C are homogeneously distributed in CaO 2 @ DOX@ZIF-67. Powder X-ray diffraction (PXRD) analysis of Adv. Sci. 2019, 6, 1902137 Scheme 1. Schematic of the CaO 2 @DOX@ZIF-67 synthetic process and the enhancement of combined chemo/chemodynamic therapy by CaO 2 @DOX@ZIF-67 in a tumor cell. CaO 2 and CaO 2 @DOX@ZIF-67 is presented in Figure 1d . The as-prepared CaO 2 exhibited distinct peaks (2θ) at 30.1°, 35.6°, and 47.3°, which were identical with the values reported in the literature for CaO 2 (card number 03-0865). [27] After encapsulation by DOX and ZIF-67, the typical diffraction peaks indexed to CaO 2 are not obvious, which might be ascribed to the low crystallinity of CaO 2 . In contrast, ZIF-67 is highly crystalline, and we can observe its dominant peaks in CaO 2 @DOX@ZIF-67. [28] As shown in Figure 1e , the BET surface area of CaO 2 @DOX@ ZIF-67 was calculated to be 508.8 m 2 g −1 , which is much lower than that of ZIF-67 (1492.5 m 2 g −1 ). X-ray photoelectron spectroscopy (XPS) was further used to characterize the chemical composition and chemical state of CaO 2 @DOX@ZIF-67. The XPS survey spectrum showed that CaO 2 @DOX@ZIF-67 is composed of Ca, O, Co, N, and C ( Figure 1f ). As shown in Figure 1g , the high-resolution spectrum of Ca 2p displayed two characteristic peaks at 346.4 eV (Ca 2p3/2) and 350.1 eV (Ca 2p1/2), indicating the presence of Ca 2+ . [29] The photoelectron peak at 533.1 eV of O1s can be attributed to O 2 2− , [30] which is the other component of CaO 2 (Figure 1h ). Figure 1i displays two main photoelectron peaks at 780.8 and 796.4 eV, which can be assigned to Co 2p3/2 and Co 2p1/2, respectively. The energy gap between the main peak of Co 2p and the satellite peak (sat. 1, 785.8 eV) is 5.0 eV, which suggests that Co(II) is the main form in CaO 2 @DOX@ZIF-67. [31] All the above results confirmed that the CaO 2 @DOX@ZIF-67 nanoparticles have been successfully constructed.
UV-vis spectrophotometry was used to determine the loading of DOX in CaO 2 @DOX@ZIF-67 and its release behavior. According to the standard curve ( Figure S2 , Supporting Information), the loading capacity of DOX was quantitatively determined to be 5.2 wt%. Even in CaO 2 @DOX, the loading efficiency of DOX was only 7.2%. This low loading capacity might be because the coordination sites on surface of the CaO 2 were completely occupied. The release of DOX from CaO 2 @DOX@ZIF-67 was measured in buffers of different pH. As shown in Figure 2a , there was no release of DOX at pH 7.4, and even at pH 6.5, the cumulative release of DOX was only 30%. In contrast, once the pH value was lowered to 5.0, more than 90% of the DOX was released within 15 min. These results indicated that the release of DOX is triggered by pH, which could be ascribed to the pH-sensitivity of ZIF-67. Figure S3 (Supporting Information) showed that ZIF-67 could quickly decompose and release Co 2+ within 2 min at pH 5.0. Then, the stability of CaO 2 @DOX@ZIF-67 in serum and phosphate buffered saline (pH 7.4) was also investigated using DLS. Figure S4 (Supporting Information) showed that no detectable changes in particle size was observed within 24 h.
After the decomposition of ZIF-67, the unprotected CaO 2 is predicted to react with water to produce O 2 and H 2 O 2 . The generation of H 2 O 2 arising from the reaction of CaO 2 and water was evaluated using an H 2 O 2 assay kit. As shown in Figure 2b , more yellow titanium peroxide complex (TiO 2
2+
) was obtained in the presence of CaO 2 @DOX@ZIF-67. The next prediction is that the generated H 2 O 2 will further react with Co 2+ ions released from ZIF-67 through a Fenton-like reaction to produce highly toxic •OH. To prove this, we used 5,5-dimethyl-1-pyrroline N-oxide (DMPO), a •OH trapping agent. The production of •OH was measured by electron spin-resonance (ESR) spectrometry, in which the DMPO/•OH adduct presents a characteristic 1:2:2:1 four-line signal. [7] Interestingly, the signal intensity of the adduct is dependent on the pH. As shown in Figure 2c , the ESR signal was intensified when the pH value was lowered from 6.5 to 5.0. However, no ESR signals are observed at Adv. Sci. 2019, 6, 1902137 pH 7.4. These results further confirmed that CaO 2 @DOX@ ZIF-67 is stable in physiologically neutral conditions, while under acidic conditions, •OH radicals are effectively generated by Co 2+ -catalyzed decomposition of the produced H 2 O 2 through a Fenton-like reaction. As control, the production of •OH was also measured in the presence of CaO 2 @DOX and ZIF-67 + H 2 O 2 , respectively. The results further demonstrated that Co 2+ ions acted as the necessary Fenton-like reaction catalyst driving generation •OH radicals ( Figure S5 , Supporting Information). In addition, the generation of •OH was further evaluated at pH 5.0 using 3,3′,5,5′-tetramethylbenzidine (TMB), which is oxidized by •OH to form ox-TMB. [32] As shown in Figure 2d , the UV-vis absorption spectra revealed that the production of ox-TMB was dependent on the concentration of CaO 2 @ DOX@ZIF-67. In order to quantitatively determine the amount of H 2 O 2 generated from CaO 2 @DOX@ZIF-67, the absorbance values of the ox-TMB were measured at 370 nm and a standard curve was plotted ( Figure S6 , Supporting Information). According to the standard curve, 58.4 µmol of H 2 O 2 is produced by 1 mg of CaO 2 @DOX@ZIF-67. This would greatly improve the efficacy of CDT.
The amount of oxygen generated by CaO 2 @DOX@ZIF-67 was also determined. Twenty milligrams of CaO 2 @DOX@ ZIF-67 were added to 20 mL of buffer solution (pH 5.0) and the concentration of dissolved oxygen was monitored by a portable oxygen meter in real time. As shown in Figure 2e , compared with degassed water, the solution of CaO 2 @DOX@ZIF-67 had a higher oxygen concentration (78 µmol g −1 ), which would improve the efficacy of DOX treatment. In order to visualize the formation of oxygen bubbles, a video was taken of the reaction of CaO 2 @DOX@ZIF-67 with H 2 O at pH 5.0 (Video S1 is available in the Supporting Information). In addition, the exclusive formation of O 2 was confirmed using gas chromatography (GC). Figure 2f shows that the gas generated from CaO 2 @DOX@ZIF-67 had the same retention time as pure O 2 . These results indicate the excellent and specific O 2 -generating capacity of CaO 2 @DOX@ZIF-67. In summary, our data demonstrate that CaO 2 @DOX@ZIF-67 has many properties which hold promise for enhanced chemo/chemodynamic therapy.
Encouraged by the efficient production of •OH and O 2 , we further investigated the in vitro anticancer effect of CaO 2 @ DOX@ZIF-67. The viability of MCF-7 cells treated with CaO 2 @ DOX@ZIF-67 was evaluated by standard methyl thiazolyl tetrazolium (MTT) assay. As shown in Figure 3a , the viabilities of MCF-7 cells are highly dependent on the dosage of CaO 2 @ DOX@ZIF-67 and the pH value. At the same concentration of CaO 2 @DOX@ZIF-67, the cytotoxic effect was greater under slightly acidic conditions (pH 6.5) than under neutral conditions (pH 7.4). These results indicate that the cytotoxic effect of CaO 2 @DOX@ZIF-67 is mainly triggered by acidic conditions. Adv. Sci. 2019, 6, 1902137 The colocalization assay demonstrated the acidic condition was mainly provided by the lysosome of MCF-7 cells ( Figure S7 , Supporting Information).
As expected, the cytotoxic effect of CaO 2 @DOX@ZIF-67 on MCF-7 cells is independent of the concentration of oxygen owing to the capacity of CaO 2 @DOX@ZIF-67 to relieve hypoxia. Figure 3b shows that CaO 2 @DOX@ZIF-67 exhibited similarly high levels of cytotoxicity toward MCF-7 cells under both normoxic (21% O 2 ) and hypoxic (1% O 2 ) conditions. The cytotoxic effects of CaO 2 @DOX and CaO 2 @ZIF-67 on MCF-7 cells were also independent of the oxygen concentration. In contrast, the viability of cells treated with free DOX or DOX@ZIF-67 is clearly higher under hypoxic conditions than under normoxic conditions. All the above results confirm that the oxygen generated by CaO 2 is beneficial for improving the efficacy of DOX. The excellent cytotoxicity of CaO 2 @DOX@ZIF-67 compared to the other groups can be ascribed to the combined chemo/chemodynamic treatment effect.
To verify the effective intracellular production of •OH, we used the ROS fluorescence probe 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) (Figure 3c ). Compared with the control group, DOX@ZIF-67-treated MCF-7 cells showed a low level of fluorescence, which can be ascribed to conversion of endogenous intracellular H 2 O 2 by Co 2+ to generate •OH. However, strong green fluorescence was observed in MCF-7 cells treated with CaO 2 @DOX@ZIF-67. These results further indicate that CaO 2 @DOX@ZIF-67 can significantly increase the intracellular level of H 2 O 2 owing to the presence of CaO 2 , and the H 2 O 2 then disintegrates to yield •OH through a Fenton-like reaction catalyzed by Co 2+ ions.
In addition, the combined treatment effect of CaO 2 @DOX@ ZIF-67 was further evaluated in MCF-7 derived multicellular tumor spheroids (MCTSs) using alive-dead cell staining assay with calcein acetoxymethyl ester (calcein AM, green fluorescence) and propidium iodide (PI, red fluorescence) (Figure 3d ). Compared with the control MCTSs (treated with PBS), the MCTSs treated with CaO 2 @DOX@ZIF-67 showed a drastic increase in red fluorescence resulting from severe cell apoptosis. Statistical analysis data showed that the intensity of red fluorescence increased about 31-fold, and green fluorescence reduced to 1/10 compared to the control group ( Figure S8 , Supporting Information). In comparison, only partial apoptosis was observed in the MCTSs incubated with free-DOX, DOX@ ZIF-67, CaO 2 @DOX, and CaO 2 @ZIF-67. These results are in accordance with the MTT assay, and further demonstrate the combined chemo/chemodynamic treatment effect of CaO 2 @ DOX@ZIF-67.
The promising antitumor effect in vitro encouraged us to further evaluate the combined chemo/chemodynamic therapeutic performance of CaO 2 @DOX@ZIF-67 against MCF-7 breast tumor xenografts in nude mice. MCF-7 tumor-bearing female Nu/Nu nude mice were randomly separated into groups when the tumor volume reached 100 mm 3 , and used to evaluate different treatments after intratumoral injection. To validate the generation of •OH in vivo, we first used the near-infrared (NIR) fluorescence dye Cy7, which is degraded by •OH and therefore acts as a sensor. Tumor-bearing mice received an intratumoral injection of CaO 2 @DOX@ZIF-67 + Cy7 or Cy7 alone. In the group treated with Cy7 only, no obvious change in fluorescence was observed. In contrast, the fluorescence of the group treated with CaO 2 @DOX@ZIF-67 + Cy7 decreased quickly (Figure 4a) . It can be seen from Figure 4b that about 50% of the Cy7 was degraded within 6 h after intratumoral injection of CaO 2 @ DOX@ZIF-67 + Cy7. The results confirm the generation of •OH in the tumors.
Next, the oxygen-generating capacity of CaO 2 @DOX@ ZIF-67 in tumors was evaluated by measuring oxygenated hemoglobin (HbO 2 ) at 850 nm with a photoacoustic (PA) imaging system. Tumor-bearing mice received an intratumoral injection of saline (control), DOX@ZIF-67, and CaO 2 @DOX@ ZIF-67, respectively. As shown in Figure 4c , the PA signal intensity of HbO 2 in the group treated with CaO 2 @DOX@ ZIF-67 is obviously higher. Compared with the saline (control) and DOX@ZIF-67-treated groups, the amount of intratumoral oxygen in the CaO 2 @DOX@ZIF-67-treated tumors increased approximately eightfolds and fourfolds, respectively ( Figure S9 , Supporting Information). These results were further verified by immunofluorescence staining assay using an antibody against hypoxia inducible factor-1α (HIF-1α) (Figure 4d ). The group treated with PBS and DOX@ZIF-67 displayed significant green fluorescence, which suggests that HIF-1α is over expressed. However, owing to the elevated oxygen level in the tumor, the group treated with CaO 2 @DOX@ZIF-67 only exhibited slight green fluorescence, which indicates that CaO 2 @DOX@ZIF-67 can serve as an oxygen generator to overcome the hypoxia in tumor tissues.
We then used the xenograft model to evaluate the antitumor performance of different treatments after intratumor injection. Tumor-bearing mice were administered with six treatments: saline (control), free DOX, DOX@ZIF-67, CaO 2 @DOX, CaO 2 @ ZIF-67, and CaO 2 @DOX@ZIF-67. In the groups treated with free DOX and DOX@ZIF-67, there was modest inhibition of tumor growth compared to the control group (Figure 5a) . These treatments do not generate O 2 or H 2 O 2 ; therefore the tumor cells will be insensitive to DOX, and there will be insufficient H 2 O 2 for effective CDT. Tumor growth was obviously inhibited in the CaO 2 @DOX and CaO 2 @ZIF-67 groups, and this inhibition possibly resulted from the generation of O 2 and H 2 O 2 from CaO 2 . Even so, tumor proliferation was not inhibited completely in these groups. The group treated with CaO 2 @DOX@ ZIF-67 exhibited the strongest tumor suppression effect, presumably due to the combined effect of chemotherapy and chemodynamic therapy. Images of representative tumors on day 21 after administration confirmed this result (Figure 5c ). Hematoxylin-eosin (H&E) staining showed significant tumor cell necrosis and tumor tissue damage in the CaO 2 @DOX@ ZIF-67-treated group compared with others ( Figure 5d ). Correspondingly, the terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling (TUNEL) staining assay also revealed a higher level of apoptosis (Figure 5d ). Furthermore, during the treatment, no obvious body weight changes (Figure 5b ) or major organ damage was observed in any of the groups (Figure S10 , Supporting Information). This suggests that CaO 2 @DOX@ZIF-67 has potential for clinical application.
In summary, a pH-triggered nanocatalytic medicine, CaO 2 @ DOX@ZIF-67, was successfully constructed via a bottomup approach for combined chemo/chemodynamic therapy of tumors. Under weakly acidic conditions, CaO 2 @DOX@ZIF-67 can be broken down to rapidly release the Fenton-like catalyst Co 2+ and DOX. Subsequently, the unprotected CaO 2 reacts with H 2 O to simultaneously generate O 2 and H 2 O 2 , which will improve the efficacy of DOX and CDT, respectively. Both the in vitro and in vivo results demonstrated that CaO 2 @DOX@ ZIF-67 has an excellent antitumor performance and low systemic toxicity. Therefore, this nanocatalytic medicine could be a promising candidate for combined pH-responsive chemo/ chemodynamic therapy.
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